ClinicalTrials.Veeva
Menu

Find clinical trials for Prostate Cancer in Berlin, BE

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Breast Cancer
Cancer
Ovarian Cancer
Neoplasm Metastasis
Non-Small-Cell Lung Carcinoma
Colorectal Cancer

Prostate Cancer trials near Berlin, BE, DEU:

A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation (EvoPAR-PR02)

with high-risk and very high-risk localised/locally advanced prostate cancer with a breast cancer gene mutation (BRCAm)....

Enrolling
Prostate Cancer
Drug: Saruparib
Drug: Abiraterone + Prednisolone/Prednisone

Phase 3

AstraZeneca
AstraZeneca

Berlin, Germany and 329 other locations

Locations recently updated

The primary objective of this study is to compare overall survival (OS) in participants receiving xaluritamig plus abiraterone against investigator's...

Enrolling
Metastatic Castration-resistant Prostate Cancer
Drug: Xaluritamig
Drug: Docetaxel

Phase 3

Amgen
Amgen

Berlin, Germany and 135 other locations

This is a phase III, randomized, open-label, multi-center study to assess the efficacy of treatment intensification with docetaxel plus apalutamide a...

Enrolling
Metastatic Hormone-sensitive Prostate Cancer
Drug: Apalutamide (Erleada™) 60 mg or 240 mg tablets
Drug: Docetaxel

Phase 3

Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD

Berlin, Germany and 55 other locations

The purpose of this study is to evaluate the efficacy and safety of apalutamide in adult men with high-risk non-metastatic castration-resistant prostate...

Active, not recruiting
Prostatic Neoplasms
Drug: Apalutamide
Drug: Placebo

Phase 3

Aragon Pharmaceuticals

Berlin, Germany and 378 other locations

The intention of the study is to demonstrate superiority of AZD2265 relative to standard of care treatments by assessment of radiographic progression...

Enrolling
Metastatic Castration-resistant Prostate Cancer
Drug: Abiraterone
Drug: Rezvilutamide

Phase 3

AstraZeneca
AstraZeneca

Berlin, Germany and 88 other locations

survival (rPFS) per 1) Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 for soft tissue and/or Prostate Cancer Wo...

Active, not recruiting
Hormone-Sensitive Prostate Cancer
Drug: Capivasertib
Other: Placebo

Phase 3

AstraZeneca
AstraZeneca

Berlin, Germany and 322 other locations

The main objective of the study is to compare overall survival in participants receiving xaluritamig versus investigator's choice (cabazitaxel or sec...

Active, not recruiting
Metastatic Castration-resistant Prostate Cancer
Drug: Cabazitaxel
Drug: Enzalutamide

Phase 3

Amgen
Amgen

Berlin, Germany and 164 other locations

The purpose of the study is to assess and evaluate dosimetry, safety, and tolerability following administration of up to 12 cycles of (177Lu) vipivot...

Enrolling
Metastatic Castration-Resistant Prostate Cancer
Drug: Gonadotropin-releasing hormone (GnRH) analogues
Drug: AAA617

Phase 1

Novartis
Novartis

Berlin, Germany and 20 other locations

hormonal therapy (NHT) in men with metastatic castration-resistant prostate cancer (mCRPC) who have previously been treated with on ...

Active, not recruiting
Metastatic Prostate Cancer
Prostate Adenocarcinoma
Drug: Cabozantinib
Drug: Abiraterone Acetate

Phase 3

Exelixis
Exelixis

Berlin, Germany and 279 other locations

The intention of the study is to demonstrate superiority of Saruparib (AZD5305) + physician's choice NHA relative to placebo + physician's choice NHA...

Active, not recruiting
Metastatic Castration-Sensitive Prostate Cancer
Drug: Abiraterone Acetate
Drug: Placebo

Phase 3

AstraZeneca
AstraZeneca

Berlin, Germany and 321 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems